129 related articles for article (PubMed ID: 3908127)
21. Renal tubular function of workers exposed to low levels of cadmium.
Chia KS; Ong CN; Ong HY; Endo G
Br J Ind Med; 1989 Mar; 46(3):165-70. PubMed ID: 2649143
[TBL] [Abstract][Full Text] [Related]
22. [Clinical multivariate statistical analysis of nephrotoxicity induced by cisplatin].
Ding DC
Zhonghua Zhong Liu Za Zhi; 1992 Jan; 14(1):64-6. PubMed ID: 1396050
[TBL] [Abstract][Full Text] [Related]
23. Cyclosporine and renal enzyme excretion.
Whiting PH; Thomson AW; Simpson JG
Clin Nephrol; 1986; 25 Suppl 1():S100-4. PubMed ID: 2871955
[TBL] [Abstract][Full Text] [Related]
24. Renal tubular function in patients treated with high-dose cisplatin.
Daugaard G; Abildgaard U; Holstein-Rathlou NH; Bruunshuus I; Bucher D; Leyssac PP
Clin Pharmacol Ther; 1988 Aug; 44(2):164-72. PubMed ID: 2840230
[TBL] [Abstract][Full Text] [Related]
25. Urinary excretion of beta 2-glycoprotein-1 (apolipoprotein H) and other markers of tubular malfunction in "non-tubular" renal disease.
Flynn FV; Lapsley M; Sansom PA; Cohen SL
J Clin Pathol; 1992 Jul; 45(7):561-7. PubMed ID: 1381383
[TBL] [Abstract][Full Text] [Related]
26. Mercury in dental restoration: is there a risk of nephrotoxicity?
Mortada WL; Sobh MA; El-Defrawy MM; Farahat SE
J Nephrol; 2002; 15(2):171-6. PubMed ID: 12018634
[TBL] [Abstract][Full Text] [Related]
27. N-acetyl-beta-glucosaminidase and beta 2-microglobulin. Their urinary excretion in patients with renal parenchymal disease.
Sherman RL; Drayer DE; Leyland-Jones BR; Reidenberg MM
Arch Intern Med; 1983 Jun; 143(6):1183-5. PubMed ID: 6190447
[TBL] [Abstract][Full Text] [Related]
28. Tubule recovery after obstructive nephropathy relief: the value of enzymuria and microproteinuria.
Tataranni G; Farinelli R; Zavagli G; Logallo G; Farinelli A
J Urol; 1987 Jul; 138(1):24-7. PubMed ID: 2885428
[TBL] [Abstract][Full Text] [Related]
29. [A clinical evaluation of the protective effect of fosfomycin (FOM) against the cis-diamminedichloroplatinum (CDDP)-induced nephrotoxicity].
Saito M; Masaki T; Kato H; Numasaka K
Hinyokika Kiyo; 1988 May; 34(5):782-9. PubMed ID: 3051938
[TBL] [Abstract][Full Text] [Related]
30. Specific developmental profiles of lysosomal and brush border enzymuria in the human.
Simeoni U; Schnitzler B; Massfelder T; Hirt C; Koehl C; Hamel G; Helwig JJ; Messer J; Geisert J; Willard D
Biol Neonate; 1994; 65(1):1-6. PubMed ID: 7605402
[TBL] [Abstract][Full Text] [Related]
31. Amino-aciduria and enzymuria in patients with artificial heart valves.
Chan PC; Chow WH; Tam SC; Cheng IK; Chan MK
Nephron; 1992; 62(1):18-21. PubMed ID: 1436285
[TBL] [Abstract][Full Text] [Related]
32. Measurement of urinary N-acetyl-b-D-glucosaminidase in adult patients with cystic fibrosis: before, during and after treatment with intravenous antibiotics.
Etherington C; Bosomworth M; Clifton I; Peckham DG; Conway SP
J Cyst Fibros; 2007 Jan; 6(1):67-73. PubMed ID: 16844430
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of enzymuria as an indicator of amikacin-induced renal damage in guinea pigs.
Suzuki CA; Thomas BH; Mueller R
Toxicol Lett; 1992 Aug; 62(1):101-14. PubMed ID: 1509502
[TBL] [Abstract][Full Text] [Related]
34. Effects of sevoflurane and isoflurane on renal function and on possible markers of nephrotoxicity.
Higuchi H; Sumita S; Wada H; Ura T; Ikemoto T; Nakai T; Kanno M; Satoh T
Anesthesiology; 1998 Aug; 89(2):307-22. PubMed ID: 9710388
[TBL] [Abstract][Full Text] [Related]
35. [Acute nephrotoxicity by CDDP (on tubular damage)].
Higuchi K; Negoro Y; Suzuki M; Noguchi M; Nakanishi M; Ishihara M; Nakano M
Gan To Kagaku Ryoho; 1991 Jan; 18(1):85-9. PubMed ID: 1987905
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic potential of urinary enzymes and beta 2-microglobulin in acute urinary tract infection.
Sandberg T; Bergmark J; Hultberg B; Jagenburg R; Trollfors B
Acta Med Scand; 1986; 219(5):489-95. PubMed ID: 2874689
[TBL] [Abstract][Full Text] [Related]
37. [Measurement of creatinine clearance and urinary NAG for the evaluation of cis-platinum induced nephrotoxicity].
Kubota A; Yoshida T; Tsukuda M; Furukawa S; Miyata K; Mochimatsu I; Sawaki S
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2599-605. PubMed ID: 2774590
[TBL] [Abstract][Full Text] [Related]
38. Urinary N-acetyl-beta-D-glucosaminidase and beta 2-microglobulin excretion in primary nephrotic children.
Calişkan S; Hacibekiroğlu M; Sever L; Ozbay G; Arisoy N
Nephron; 1996; 74(2):401-4. PubMed ID: 8893163
[TBL] [Abstract][Full Text] [Related]
39. Changes in urinary excretion of endothelin-1-like immunoreactivity in patients with testicular cancer receiving high-dose cisplatin therapy.
Takeda M; Komeyama T; Tsutsui T; Mizusawa T; Go H; Hatano A; Tanikawa T
Am J Kidney Dis; 1994 Jul; 24(1):12-6. PubMed ID: 8023817
[TBL] [Abstract][Full Text] [Related]
40. Temporal changes in urinary levels of cadmium, N-acetyl-β-d-glucosaminidase and β2-microglobulin in individuals in a cadmium-contaminated area.
Kim YD; Yim DH; Eom SY; Moon SI; Park CH; Kim GB; Yu SD; Choi BS; Park JD; Kim H
Environ Toxicol Pharmacol; 2015 Jan; 39(1):35-41. PubMed ID: 25434760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
